What does it mean to build something that has never existed before?

In this episode of StartUp Health NOW, Unity Stoakes sits down with CEO & Co-founder Valerie Gharagouzloo and Chief Science Officer & Co-founder Codi Gharagouzloo, PhD, of Imaginostics, the health technology company reimagining what MRI can tell us about the human body. Their platform, built on a technology invented by Codi during his PhD research in 2012, creates a new quantitative data layer inside existing MRI scanners, one that replaces toxic contrast agents, delivers images judged ten times better than the gadolinium standard, and generates vascular biomarkers measurable for the first time at the individual patient level.

StartUp Health community members Valerie and Codi break down the difference between their two platforms, ImagiView™ and ImagiSight™, explain why blood-brain barrier leakage matters for Alzheimer's and how they are finally able to measure it in individual patients, and share what their commercialization partnership with Siemens means for getting this technology into hospitals.

Twice nominated for the Prix Galien, backed by four federal research agencies, and now running a 96-patient study funded by the Alzheimer's Drug Discovery Foundation, Imaginostics is one of the most rigorously validated zero-to-one technologies in health innovation today.